Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for SNDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -24.11M
March 31, 2026 -13.71M
December 31, 2025 -6.995M
September 30, 2025 -7.300M
June 30, 2025 -8.942M
March 31, 2025 -15.65M
December 31, 2024 -16.29M
September 30, 2024 -6.635M
June 30, 2024 -6.882M
March 31, 2024 -5.547M
December 31, 2023 -8.294M
September 30, 2023 -7.335M
June 30, 2023 -7.437M
March 31, 2023 -8.154M
December 31, 2022 -15.16M
Date Value
September 30, 2022 -5.956M
June 30, 2022 -7.028M
March 31, 2022 -8.291M
December 31, 2021 -2.935M
September 30, 2021 -29.70M
June 30, 2021 287.55M
March 31, 2021 675.24M
December 31, 2020 80.55M
September 30, 2020 16.28M
June 30, 2020 12.25M
March 31, 2020 -7.586M
December 31, 2019 -2.572M
September 30, 2019 130.51M
June 30, 2019 125.24M
March 31, 2019 29.96M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
CannaPharmaRx, Inc. 0.1824M
Bakhu Holdings Corp. --
SpeakEasy Cannabis Club Ltd. --
Tilray Brands, Inc. 68.44M
Clearmind Medicine, Inc. 4.653M